Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
The company launched in November 2024 with a specific mission: provide physician-formulated nutritional support for people using GLP-1 receptor agonist medications for weight management
In the phase 3 ATTAIN-2 trial , adults with obesity and type 2 diabetes who took orforglipron lost an average of 5.1%9.6% over 72 weeks, compared to 2.5% in those who took a placebo
Looking forward to ordering more
Types and principal uses Tuberculin syringe There is only one type of tuberculin syringe with a 1.0 cc or mL volume capacity
It validates years of innovative R&D and will soon offer a tailored, evidence-based treatment option for Chinas overweight and obese population. Strategic Partnerships and Future Plans Mazdutide, known as OXM3 in early development, was co-developed under an exclusive licensing agreement between Innovent Biologics and Eli Lilly for the China market
US$ 21.17
US$ 28.48
US$ 24.82
US$ 25.00
US$ 27.43
US$ 23.29
